SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,417.34 |
Enterprise Value ($M) | 2,125.23 |
Book Value ($M) | 56.08 |
Book Value / Share | 0.44 |
Price / Book | 25.52 |
NCAV ($M) | -387.08 |
NCAV / Share | -3.07 |
Price / NCAV | -3.66 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.69 |
Return on Assets (ROA) | -0.67 |
Return on Equity (ROE) | -1.29 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.09 |
Current Ratio | 6.09 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 570.54 |
Assets | 1,013.69 |
Liabilities | 957.62 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 3.55 |
Operating Income | -601.08 |
Net Income | -599.49 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -462.85 |
Cash from Investing | -420.07 |
Cash from Financing | 870.52 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Sarepta Therapeutics, Inc. | 9.50 | ||
13G/A | Avoro Capital Advisors LLC | 9.60 | 35.32 | |
13G | State Street Corp | 4.80 | -5.32 | |
13G/A | Vanguard Group Inc | 10.01 | 16.23 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
315,080 | 2,105,290 | 14.97 | |
600,938 | 3,475,480 | 17.29 | |
364,249 | 1,658,736 | 21.96 | |
282,191 | 1,186,891 | 23.78 | |
(click for more detail) |
Similar Companies | |
---|---|
APLS – Apellis Pharmaceuticals, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
ARVN – Arvinas, Inc. | ASMB – Assembly Biosciences, Inc. |
ATRA – Atara Biotherapeutics, Inc. |